Close Menu

NEW YORK (GenomeWeb) – Advanced Biological Laboratories will market and distribute a next-generation sequencing-based test for tuberculosis from the Translational Genomics Research Institute under a licensing deal announced today.

The test, called DeepCheck-TB, is currently available for research use only. As part of the agreement announced by TGen, ABL will distribute a compact, portable, and affordable diagnostic model that physicians can use to determine the most appropriate treatment for individual TB patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
22
Sponsored by
Qiagen

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.